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Abstract Integrating nanotechnology into useable devices re-
quires a combination of bottom up and top down methodolo-
gy. Often the techniques to measure and control these different
components are entirely different, so methods that can analyse
the nanoscale component in situ are of increasing importance.
Here we describe a strategy that employs a self-assembling
monolayer of engineered protein chimeras to display an array
of oriented antibodies (IgG) on a microelectronic device for
the label free detection of influenza nucleoprotein. The struc-
tural and functional properties of the bio-interface were
characterised by a range of physical techniques including sur-
face plasmon resonance, quartz-crystal microbalance and neu-
tron reflectometry. This combination of methods reveals a
13.5 nm thick engineered-monolayer that (i) self-assembles
on gold surfaces, (ii) captures IgG with high affinity in a
defined orientation and (iii) specifically recognises the influ-
enza A nucleoprotein. Furthermore we also show that this
non-covalent self-assembled structure can render the dissoci-
ation of bound IgG irreversible by chemical crosslinking in
situ without affecting the IgG function. The methods can thus
describe in detail the transition from soluble engineered mol-
ecules with nanometre dimensions to an array that demon-
strates the principles of a working influenza sensor.
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Abbreviations
BS(PEG)5 Bis(succinimidyl) penta(ethylene glycol)
BSSS Bis(sulfosuccinimidyl) suberate
ctOmpA Circularly permuted transmembrane domain
of E. coli outer membrane protein A
GGZctOmpA N-terminal tandem pair of B domains from
protein Gwith a C-terminal ctOmpA scaffold
IgG Immunoglobulin G
mAb245 Mouse monoclonal IgG raised against rNP
mAb108 Mouse monoclonal IgG raised against rNP
(different epitope to mAb245)
NP Native nucleoprotein from influenza
NR Neutron reflectometry
nSLD Neutron scattering length density
PBS Phosphate buffered saline
QCM-D Quartz-crystal microbalance with dissipation
monitoring
rNP Recombinant nucleoprotein
SPR Surface plasmon resonance
thioPEG 1-mercaptoundec-11-yltriethylene glycol
1 Introduction
Self-assembly is the most effective route to the creation of
complex nanoscale components and, by exploiting specific
non-covalent interactions, highly ordered structures can be
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formed (Fletcher et al. 2013; Yu et al. 2014). In some cases
these supramolecular assemblies need to be integrated into
microscale sensors and actuators. In this paper we address
the creation of a highly efficient immunosensor by integration
of top down manufacture and bottom up self-assembly of
engineered proteins. Whilst the surface immobilisation of an-
tibodies provides the opportunity to create biosensors and oth-
er targeted nanoscale diagnostic devices, the immobilised
components can be either randomly arranged or oriented for
optimal antigen capture (Trilling et al. 2013). The simplest
way to immobilise an antibody is through physical adsorption
to a surface such as silicon. In the case of adsorption of im-
munoglobulin G (IgG) to silica surfaces, the IgG will adsorb
with a flat-on orientation with some overlap of IgG molecules
at higher surface coverage (Xu et al. 2006a). With physical
adsorption of IgG, antigen can still be bound to the antibody,
even with an albumin blocking agent co-adsorbed (Cowsill
et al. 2014). However, the theoretical maximum binding ratio
is rarely achieved, particularly at high antibody surface cover-
age (Xu et al. 2006b, 2007). On the other hand, oriented an-
tibody immobilisation enhances antigen binding as all the
binding regions face away from the surface, increasing the
potential to capture antigen (Huy et al. 2011; Le Brun et al.
2011a; Liu et al. 2012; Shen et al. 2011). Orientation thus
increases the signal per unit area allowing the device size to
be minimised. Oriented immobilisation is usually via an inter-
mediate protein immobilised to the surface which binds the
antibody through a domain outside the antigen binding region
(Trilling et al. 2013). Oriented binding has also been achieved
by other methods such as immobilisation to a surface via the
polysaccharide chain on IgG (Ho et al. 2010).
When creating biomimetic surfaces to integrate into micro-
electronics the surface that the biomolecules are to be
immobilised to has to be considered. Gold is an attractive
option as the surface is stable, conductive (Cornell et al.
1997) and amenable to label free techniques such as surface
plasmon resonance (SPR) (Skottrup et al. 2008), surface
acoustic waves (SAW) (Kogai et al. 2010), and quartz crystal
microbalance with dissipation (QCM-D) (Amano and Cheng
2005) providing a rapid and sensitive form of detection. Gold
also allows for self-assembly, the spontaneous deposition of a
defined molecular layer by chemisorption. Molecules that
self-assemble usually have a chemical group that will interact
strongly with the surface allowing for the assembling mole-
cules to orient themselves in a particular direction. Due to the
strong interaction between the assembling molecule and the
surface all the surface available for assembly becomes occu-
pied promoting the formation of a dense monolayer. The
chemistry for creating self-assembled monolayers on gold is
well understood and relatively straightforward (Dubois and
Nuzzo 1992; Love et al. 2005). Thiol-alkanes with functional
groups at the alkyl terminus can be adsorbed onto gold sur-
faces through the thiol group adsorbing to the gold surface to
form self-assembled monolayers. For example, polyethylene
glycol terminated thiol-alkanes have be used to create surfaces
that are resistant to protein adsorption (Prime and Whitesides
1993).
Previous publications have described the development of
systems where outer membrane proteins from Escherichia
coli can be used as engineered protein scaffolds on solid sup-
ports (Cisneros et al. 2006; Holt et al. 2009; Keegan et al.
2005; Terrettaz et al. 2002). The transmembrane section (res-
idues 1 to 171) of outer membrane protein A (tmOmpA) has
been engineered such that it can be immobilised to gold sur-
faces in a specific orientation through a single cysteine residue
(Shah et al. 2007). The tmOmpA was then circularly
permutated in extracellular loop 1 to create ctOmpA which
acts as a scaffold to which functional domains from other
proteins can be fused (Le Brun et al. 2011a). For example
the ctOmpA scaffold has been fused to a single or double
immunoglobulin-binding Z domain (ZctOmpA &
ZZctOmpA) from Staphylococcus aureus protein A for anti-
body binding and was used to build arrays with bound IgG for
antigen sensing (Le Brun et al. 2008, 2011a, b). However,
whilst the ZZctOmpA arrays bound rabbit IgG tightly, they
worked poorly for mouse monoclonal IgG which are the pre-
ferred component of many medical tests (Le Brun et al.
2011a).
Protein G from Streptococcus group C or G is a multi-
domain cell wall-associated protein that binds IgG and human
serum albumin. The B domain (herein referred to as protein
G), which binds IgG, has an architecture consisting of a single
α-helix packed into a three-stranded β-sheet (Gallagher et al.
1994). Whilst protein G and protein A have no sequence or
structural homology (Tashiro and Montelione 1995), both
compete for the same binding site on the constant (Fc) region
of IgG, leaving the variable antigen-binding (Fab) region free
to bind antigen (Sauer-Eriksson et al. 1995). Despite proteins
A and G competing for the same Fc binding site, protein G
binds more subclasses of IgG (Akerström et al. 1985; Björck
and Kronvall 1984). This is likely to arise from the difference
in the protein-protein interaction between protein G and pro-
tein A to Fc. The protein A-Fc interaction is mainly between
hydrophobic residues whereas that of protein G mainly con-
sists of salt bridges and hydrogen bonds between polar resi-
dues (Sauer-Eriksson et al. 1995).
Protein G and Protein A have been used as IgG capture
molecules in immunosensor devices fabricated using self-
assembled monolayers (Makaraviciute and Ramanaviciene
2013; Trilling et al. 2013). The IgG capture molecules have
been immobilised to surfaces using self-assembled mono-
layers of thiolalkanes functionalised with carboxylic acid
groups for amine cross-linking (Jyoung et al. 2006),
nitrolotriacetic acid (NTA) for binding proteins with a hexa-
histidine tag (Roth et al. 2013), or for binding biotinlyated
proteins (Jung et al. 2006). Monolayers of proteins A and G
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have been formed by direct assembly onto gold by incorpo-
rating thiol groups (Oh et al. 2004), or through the use of
fusion proteins such as glutathione S-transferase (GST) (Ha
et al. 2006) or elastin (Gao et al. 2006). This work describes an
array of ctOmpA protein G fusions designed to reduce the
dissociation of mouse monoclonal IgG. Two protein G do-
mains were fused to the N-terminus of ZctOmpA to create
the array protein GGZctOmpA. Once the GGZctOmpA is
immobilised to the gold surface the monolayer is completed
with a thiol-terminated amphiphile with a poly(ethylglycol)
head group. This amphiphilic filling molecule supports the
array protein and reduces subsequent non-specific binding
(Cisneros et al. 2006; Le Brun et al. 2011a; Terrettaz et al.
2002). The GGZctOmpA array is designed for the label free
detection of protein analytes in clinical or veterinary samples
and when loaded with a monoclonal IgG the array becomes
highly specific for the binding of defined epitopes of the target
antigen. This specificity in turn assembles oriented antigen
allowing a second different monoclonal antibody to target
another epitope on the other face of the antigen allowing a
Bsandwich assay^ of high sensitivity to be created. The target
antigen in this work is the influenza nucleoprotein (NP). NP
forms oligomers that encapsulate the genomic RNA and the
RNA polymerase of the influenza virus in ribonucleoprotein
particles (Coloma et al. 2009; Ruigrok et al. 2010; Ye et al.
2006). The nucleoprotein, highly conserved between strains
and type specific for influenza A and influenza B, has been a
preferred target protein for influenza detection over the highly
variable surface glycoproteins haemagglutinin and neuramin-
idase (Farris et al. 2010). This paper describes the in situ
physical characterisation of the entire assembly process using
surface plasmon resonance, quartz crystal microbalance with
dissipation and neutron reflectometry.
2 Materials and methods
2.1 Materials
Antibodies were purchased fromHyTest Ltd (Turku, Finland).
Molecular biology and protein purification materials were
purchased from Invitrogen, Novagen and GE Healthcare
(UK). D2O was purchased from CDN Isotopes (Canada).
Cross-linking reagents were purchased from Pierce
Scientific (Cramlington, UK). All other materials were pur-
chased from Sigma-Aldrich unless otherwise stated.
2.2 Construction of expression plasmids
DNA digestions, ligations and transformations were carried
out using standard molecular biology techniques (Sambrook
and Russell 2001). The GGZctOmpA protein was constructed
by designing a gene encoding a tandem pair of B-domains
from protein G and ligating this to a scaffold protein
(ZctOmpA) that contains a single N-terminal Z-domain fused
to a circularly permuted tmOmpA scaffold (Le Brun et al.
2011a). This construct also contains a His6-tag at the N-
terminus.
The amino acid sequence of influenza A nucleoprotein
(NP) was obtained from the NCBI Influenza Resource website
(Bao et al. 2008), reverse translated and codon optimised to
provide a DNA sequence for expression in E. coli. The gene
was synthesised by Epoch Biolabs (Texas, USA) and subse-
quently ligated into a pET3d-based expression vector that in-
corporates a His6-tag at the N-terminus of the expressed pro-
tein. This protein is referred to as recombinant NP (rNP).
2.3 Protein expression and purification
2.3.1 GGZctOmpA
GGZctOmpAwas expressed and purified as described previ-
ously for ZZctOmpA (Le Brun et al. 2011a) and a detailed
description is included in the supplementary information.
Refolding of the GGZctOmpA protein was confirmed by
Circular Dichroism spectroscopy (Supplemental Fig. S1).
2.3.2 Recombinant influenza A NP protein
Expression of rNP was carried out in E. coli BL21-AI cells in
LB broth and was induced with 0.2 % L-arabinose. The rNP
was purified from the cell lysate by immobilised metal affinity
chromatography followed by cation exchange chromatogra-
phy. The purified protein was analysed by SDS PAGE to
ensure >95 % homogeneity of rNP (~57 kDa). The binding
of anti-Influenza A NP mouse monoclonal IgGs mAb245 and
mAbA108 (HyTest) was confirmed by Western blotting (data
not shown). A detailed description of the expression and pu-
rification of rNP can be found in the supplementary
information.
2.3.3 Deuterated proteins
Deuterated proteins were produced as described for
GGZctOmpA but the media used was Silantes OD 2H rich
growth media (Silantes, Munich, Germany) which is a rich
media containing D2O for deuterium incorporation into pro-
teins. Mass spectrometry analysis to determine the level of
deuteration was carried out by the Sydney University
Proteome Research Unit. A tryptic digest of protein from a
gel slice of an SDS-PAGE band corresponding to the molec-
ular weight of the protein was analysed byMALDI-TOFmass
spectrometry. The amount of deuteration was determined by
comparing the mass of the peaks from each fragment of the
hydrogenous protein with that of the corresponding peaks in
the deuterated protein (Supplementary Table S1).
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2.4 Surface plasmon resonance (SPR)
SPR experiments used BIAcore Au sensor chips in a BIAcore
X100. The Au chip was cleaned by using piranha solution (3:1
H2SO4/H2O2 by volume) on the gold surface for 15 min
followed by copious washing with 2 % Hellmanex (Hellma,
UK) and ethanol with >18 MΩ water washes between each
step. The sensor was immersed in a 1 % (v/v) β-
mercaptoethanol (BME) in ethanol solution to passivate the
gold surface (Terrettaz et al. 2002), washed with 1 % (w/v)
SDS followed by >18 MΩ water. The running buffer for all
experiments was phosphate buffered saline (PBS, 20 mM so-
dium phosphate pH 7.6, 137 mMNaCl and 2.7 mMKCl). The
volumes and flow rates used for the assembly of the
GGZctOmpA array; binding and crosslinking of antibody;
and binding of antigen and secondary antibody are outlined
in Supplementary Tables S2, S3 and S4 respectively with
experiments repeated in triplicate.
2.5 Quartz crystal microbalance with dissipation
(QCM-D)
The QsenseE4 instrument (Q-Sense, Gothenburg, Sweden)
with a peristaltic pump (Ismatec SA, Glattbrugg,
Switzerland) used a flow rate of 50 μL min−1, a constant
temperature of 24 °C and gold-coated sensor crystals (QSX-
301, Q-sense). The sensor crystals were cleaned and prepared
with BME in the same way as for SPR gold surfaces. The
change in frequency (Δf) was measured at its fundamental
frequency (5MHz) of the quartz crystal and for the third, fifth,
seventh, ninth and eleventh overtones of the fundamental fre-
quency. Data was processed into frequency and dissipation vs.
time with four individual experiments carried out to test for
repeatability. A decrease in frequency corresponds to an in-
creased mass on the surface of the sensor. For each overtone
the change in dissipation (ΔD) was also measured. The dissi-
pation is the proportion of energy dissipated during one cycle
of the frequency oscillation and provides information on the
viscoelastic properties of the materials deposited on the sensor
surface. Further details can be found in the supplementary
information.
2.6 Neutron reflectometry (NR)
NR experiments were carried out on the Platypus time-of-
flight neutron reflectometer (James et al. 2011; Saerbeck
et al. 2012) at the 20 MW OPAL research reactor (Sydney,
Australia) and on the Polref instrument (Webster et al. 2011) at
the ISIS pulsed neutron source (Didcot, UK). Both reflectom-
eters were used in polarised mode to enable magnetic contrast
neutron reflectometry (Holt et al. 2009; Kirby et al. 2012). The
collected data was normalised to direct beam runs collected
under identical conditions. Absolutely scaled data was
analysed using the MOTOFIT reflectivity analysis software
(Nelson 2006). A least squares fitting routine, which selects
the best fit by minimising χ2 values between model and ex-
perimental data by varying the thickness, interfacial roughness
and neutron scattering length density (nSLD) of each layer,
was utilised. Error analysis was carried out using a Monte
Carlo resampling procedure (Heinrich et al. 2009; Holt et al.
2009) (see supplementary information).
3 Results
3.1 Assembly of the GGZctOmpA array
The assembly of the GGZctOmpA array was carried out using
establishedmethods on a gold surface passivatedwith BME to
improve protein assembly and maintain structure (Cisneros
et al. 2006; Holt et al. 2009; Keegan et al. 2005; Terrettaz
et al. 2002). The GGZctOmpA was incubated on the gold
surface and this was followed with an incubation of a lipid
mimic of 1-mercaptoundecyl-11-triethylene glycol (thioPEG)
which supports the GGZctOmpA and reduces non-specific
binding in subsequent steps. Each incubation step is followed
with a 1 % SDS wash to remove non-specifically bound ma-
terial and a PBS wash to remove excess SDS (Supplementary
Figs. S2 and S3). QCM-D showed that 1.36±0.04 mg m−2 of
GGZctOmpA remained bound on the surface after a single
20 min incubation of protein solution followed by SDS/PBS
wash steps (Supplementary Fig. S3). SPR analysis of the as-
sembly process showed that a higher surface coverage can be
achieved with multiple incubation/wash steps with the gold
surface saturated with GGZctOmpA at approximately 3550
RU after three incubation/wash steps (Supplementary
Fig. S2). This corresponds to 3.55 mg m−2 of protein on the
surface (assuming 1 RU=0.001 mg m−2 (Stenberg et al.
1991)) and agrees with previous published data on the assem-
bly of ZZctOmpA (Le Brun et al. 2011a). The QCM-D shows
low values of ΔD and all overtones overlapping
(Supplementary Fig. S3a, red trace) indicating that the mono-
layer is complete with little solvent content and is rigid.
Neutron reflectometry provides real space structural data
for surfaces and interfaces along the axis perpendicular to the
lateral plane of the surface. The layer structure consisted of the
silicon wafer followed by the Permalloy layer that acts as a
binder between the silicon and the gold layer then finally the
array which is assembled on the gold surface. Based on the
results from the SPR experiments three protein incubations
and SDS/buffer washes were used to assemble GGZctOmpA
on gold surfaces for NR measurements. A measurement of
GGZctOmpA only on the gold surface was not carried out
using NR as it has been previously shown that array proteins
based on the ctOmpA scaffold can adopt many orientations on
the surface unless supported by a monolayer of thioPEG (Le
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Brun et al. 2011a). For best fitting of the NR data the array
layer had to be split into two discrete layers: one layer of the
thioPEG plus GGZctOmpA (plus solvent) which was 22±2 Å
thick and a second layer of GGZctOmpA and solvent only at
113±16 Å (Fig. 1). This made a total thickness of 135±18 Å
for the GGZctOmpA (Fig. 1) which is consistent with similar
array proteins such as ZZctOmpA at 128 Å (Le Brun et al.
2011a). The neutron scattering length density (nSLD) can be
considered the neutron’s refractive index and is sensitive to the
isotopic composition and physical density of each layer. By
comparing theoretical nSLD values with those obtained from
the fitted nSLD a volume fraction for each component can be
derived. A deuterated version of the GGZctOmpA was pro-
duced (Supplementary Table S1) as the difference in scattering
length between hydrogen and its stable isotope deuterium will
allow a deuterated GGZctOmpA to be distinguished between
hydrogenous thioPEG and IgG. Fig. 1 shows the NR data
from the array in a H2O contrast and the 113 Å layer with a
higher nSLD then that of the thioPEG containing layer and
H2O as expected. Analysis of the nSLD values of the thioPEG
plus GGZctOmpA layer shows that there is some solvent as-
sociated with the layer as there is a D2O/H2O dependent
change in the nSLD and the volume fraction of solvent is
0.143±0.019 (Table 1). This corresponds with the low dissi-
pation values seen in the QCM-D trace once the array is com-
plete (Supplementary Fig. S3a). From the nSLD of the
GGZctOmpA only layer the volume fraction of the d-
GGZctOmpA is 0.224±0.018 and this corresponds to a sur-
face coverage of 0.93±0.20 mg m−2, which is comparable to
the values observed for QCM-D although lower than the SPR
results.
3.2 Antibody and antigen binding
Binding of mouse monoclonal anti-influenza type A IgG2b
(mAb245) to the array was measured by SPR and QCM-D
(Supplemental Figs. S4 and S5). The binding of mAb245 over
a range of concentrations was investigated using SPR and
showed saturation of the array at high concentrations
(Supplemental Fig. S4). Figure 2 and Supplemental Fig. S4
demonstrate that the mAb remains tightly bound to the array
after injection, evidenced by the minimal dissociation ob-
served. A high surface coverage of GGZctOmpA was used
to best reflect a real device and gain the maximum amount
of mAb binding, therefore the kon and koff (and hence the Kd)
cannot be accurately determined between individual IgG and
GGZctOmpA molecules due to mass transport and avidity
affects. QCM-D experiments were carried out to complement
the SPR data and found that typically 1.50±0.07 mg m−2 of
mAb245 bound to the array (Supplemental Fig. S5). The
QCM-D data further confirmed slow dissociation from the
array (Supplemental Fig. S5, 25 to 40 min) which is an im-
provement compared to when the IgG capture protein is the Z
domain of protein A (Le Brun et al. 2011a). As shown by the
increase in dissipation (Supplemental Fig. S5, red trace),
bound mAb245 is non-rigid and no longer obeys the
Sauerbrey equation. The array was measured by NR with
mAb bound, using both spin up and spin down neutrons as
well as using a D2O andH2O contrast (Fig. 3a). The real-space
nSLD profile showed that the IgG layer has to be modelled as
a single layer with a thickness of 135±11 Å (Table 1 and
Fig. 3c), consistent with an IgG molecule that is in the ‘up
right’ position with the variable domain facing towards the
bulk solvent. The NR shows that there is a high water content
in the mAb245 layer with only a 0.067±0.007 volume frac-
tion of protein. This will be due to the low initial surface
coverage of the GGZctOmpA and explains the high
Fig. 1 a Magnetic contrast neutron reflectivity (points with error bars)
and fit (solid lines) of an array of deuterated GGZctOmpA surrounded
with thioPEG in a H2O contrast. b The corresponding real-space nSLD
profile with zero distance set as the interface between gold on the array.
The gold layer has been truncated to show Permalloy layer and its
different nSLD between spin up (red) and spin down (black) neutrons,
and the array layers (with an illustration in the background to depict the
different array layers) in detail
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dissipation seen the QCM-D data. Between the 135 Å IgG
layer and the 22 Å thioPEG layer there was an 18 Å layer of
high nSLDwhich corresponds to the deuterated GGZctOmpA
only (Fig. 3c). This shows that the IgG does not sit on the
protein resistant thioPEG layer.
The antigen, rNP, binds to the array through the antigen
binding domains of mAb245 and both SPR and QCM-D con-
firm that rNP binds to GGZctOmpA-immobilised mAb245
(Fig. 2 and Supplemental Fig. S5). The rNP binding was test-
ed over a concentration range of 1 to 10 000 ng mL−1 by SPR
(Fig. 2). Bound rNP was measured under the same conditions
as for bound mAb245 using NR (Fig 3b). The measured NR
data with rNP bound show small changes in the shape of the
fringes when compared to mAb245 only, suggesting that rNP
has bound but there is no great structural change. The
modelling of the NR data showed that when bound to the
array, rNP antibody layer still had to be modelled as one dis-
crete layer (Fig. 3d) as separating the antibody layer into two
layers of antibody and antigen resulted in poorer fits.
On binding of rNP to the antibody layer the overall
thickness of the layer increased to 201±22 Å, strongly
indicating that antigen is bound (Fig. 3d and Table 1).
There is little change in the nSLD of the antibody layer
after rNP addition and this is unsurprising due to the
low surface coverage of mAb245. However, the Monte
Carlo resampling for the nSLD parameter shows a clear differ-
ence in nSLD before and after rNP addition (Supplementary
Fig. S6) confirming rNP binding in Fig. 3c. Figure 4 shows the
dimensions for each component in the GGZctOmpA array plus
rNP and shows that the total thickness for the array is 241±
27 Å.
The secondary antibody used was a mouse monoclonal
anti-influenza virus type A IgG1 (mAb108) that was raised
against a different epitope of the NP protein. Binding mAb108
enhances the signal from bound rNP as shown by SPR
(Fig. 2). Although we completely saturate the available pro-
tein G domains with IgG there is some dissociation of the
primary IgG (mAb245) after injection which could result in
trace amounts of free protein G domains. The secondary anti-
body (which is also a mouse monoclonal IgG) can bind to any
free protein G molecules which would result in some back-
ground signal in the 0 ng/mL rNP case. Themass of secondary
antibody that bound to the array was 3.69±0.04 mg m−2 as
determined by QCM-D (Supplemental Fig. S5). This is a
binding ratio of mAb108 to rNP of 1:0.65 (expected 1:1).
The large increase in QCM-D dissipation shows that
mAb108 is non-rigid when bound (Supplemental Fig. S5a,
red trace).
Table 1 The fitted properties of
the completed array from neutron
reflectometry
Layer Thickness / Å nSLD / ×10−6 Å−2 Volume fraction Roughness
/ Å
Permalloy 43±1 7.36±0.10 (down) – 4
11.06±0.13 (up)
Gold 231±3 4.50a – 4
thioPEG+d-GGZctOmpA 22±2 1.19±0.16 (D2O) 0.633±0.085
(thioPEG only)
5
0.20±0.04 (H2O)
d-GGZctOmpA only 113±16b 0.64±0.05 (H2O) 0.224±0.018 5
18±3c
mAb245 only 135±11 6.33±0.05 (D2O) 0.067±0.007 5
−0.45±0.09 (H2O)
mAb245+rNP 201±22 6.19±0.04 (D2O) 0.095±0.015
(rNP only)
5
0.40±0.12 (H2O)
Subphase N/A 6.35 (D2O)
a – 18
−0.56 (H2O)a
a nSLD values were fixed at the values quoted in fits
b thickness value before antibody addition
c thickness when mAb245 is bound
Fig. 2 The binding of antibody and antigen to arrays of GGZctOmpA
measured by SPR. 30 μg mL−1 mAb245 was bound to an array of
GGZctOmpA, then rNP at a concentration range of 0 to 10
000 ng mL−1 was bound. Secondary antibody, mAb108 (30 μg mL−1),
was the final binding event before regeneration with 100 mM HCl. 1° -
mAb245 injection; T – buffer wash; A – rNP injection, 2° - mAb108
injection, H – regeneration with 100 mM HCl
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Specificity of rNP binding and the level of non-specific
binding was tested with a series of control SPR experiments.
The first experiment was bindingmAb245 and rNP to an array
of ctOmpA where the tandem pair of protein G domains is
absent and therefore cannot specifically capture IgG.
Supplementary Fig. S7 shows that neither mAb245 nor rNP
can bind to an array of ctOmpA. A second experiment was
carried out where rNP was bound to an GGZctOmpAwith a
IgG bound which is not specific for rNP. Supplemental Fig. S8
shows the binding of rNP to mouse monoclonal anti-FLAG
M2 IgG1 (which is specific for the FLAG epitope)
immobilised to an array of GGZctOmpA. Supplemental
Fig. S8b is a comparison of the relative response of rNP bind-
ing to mAb245 and anti-FLAG M2 immobilised to
GGZctOmpA with time zero set as the point of 1 μg mL−1
rNP injection. The trace shows that rNP does not bind to the
anti-FLAG M2 IgG1 but does bind to mAb245.
3.3 Cross-linking assays
To further reduce the dissociation of IgG from GGZctOmpA
arrays the IgG was chemically cross-linked to the protein G
domains of GGZctOmpA in separate experiments by two dif-
ferent cross-linkers. The first was Bis(sulfosuccinimidyl)
suberate (BSSS) which is an N-hydroxysulfosuccinimidyl
(NHS)-ester homobifunctional water soluble cross-linker with
an eight carbon spacer arm of 11.4 Å. The second linker was
Fig. 3 Reflectivity data (symbols) and fit (solid lines) of an array of d-
GGZctOmpA filled with thioPEG and with amAb245 bound only to the
array and b is the reflectivity data of the array with mAb245 and rNP
bound. Both data have the same symbols and shows the up spin states (○
and □) and down spin states (□ and ◇) as well as the D2O (○ and □) and
H2O (△ and ◇) contrasts (spin up H2O absent in b). The data between the
D2O and H2O contrasts is offset for clarity. c The corresponding real-
space nSLD profiles of the array with mAb245 bound from the gold
interface and d) is the corresponding real-space nSLD profile of the
array from the gold interface with mAb245 and rNP bound
Fig. 4 The dimensions of each component of a GGZctOmpA array
before and after IgG and rNP binding. ctOmpA is shown in light green
and is bound to the gold surface and is surrounded by thioPEG (the
molecular packing is not represented accurately) with a protein A Z
domain linker (dark green) and a tandem pair of B domains from
protein G (red) to which there is an IgG (blue) bound at the Fc region.
Bound to the IgG Fab regions there is NP (orange) to which a secondary
IgG can be bound (not shown)
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Bis(succinimidyl) penta(ethylene glycol) (BS(PEG)5), which
is a linker with a pentaethylene glycol spacer of 21.7 Å. Both
cross-linkers are amine – to – amine cross-linkers that are ideal
for cross-linking IgGwhich havemany surface exposed lysine
residues. The cross-linking reagent at a final concentration of
0.5 mM in PBS buffer was incubated with the preformed IgG
array and the reaction was terminated with 1.0 M Tris–HCl
pH 6.8 (Fig. 5a and Supplemental Fig. S9). Non-cross-linked
antibody was removed by washing with 100 mMHCl follow-
ed by a PBS wash. The effectiveness of the cross-linking was
assessed by comparing the amount of mAb245 bound to the
array before the addition of the cross-linking agent to the
amount bound after the HCl and PBS wash steps (the areas
marked with the letter ‘A’ in Fig. 5a). Both cross-linking
agents were found to cross-link with approximately 98±1 %
efficiency. The effect of the cross-linking on the array’s ability
to bind rNP and mAb108 was tested and mAb245 cross-
linked to an array of GGZctOmpA retained the capacity to
bind rNP. By comparing Figs. 2 and 5 cross-linked mAb245
binds rNP to the same extent as non-cross-linked mAb245
across all bulk rNP concentrations. Furthermore, the array
can be regenerated, by washing with 100 mM HCl to remove
the rNP, leaving the cross-linked mAb245 in place (Fig. 5).
This allows for multiple cycles of antigen binding and array
regeneration without the need to replenish the array with pri-
mary IgG on each new addition of antigen. Secondary anti-
body (mAb108) binding to antigen captured by cross-linked
mAb245 was also demonstrated with SPR (Fig. 5b).
4 Discussion
The analytical methods provide a comprehensive picture of
the processes occurring during self-assembly and the combi-
nation of SPR, QCM-D and NR provides both overlap and
complementarity. Protein G B-domains were successfully
fused to the ctOmpA scaffold with a protein A Z-domain as
a linker molecule. The structure of GGZctOmpA could be
checked in solution using circular dichroism spectroscopy
(Supplementary Fig. S1) before forming self-assembled
monolayers on gold surfaces (Fig. 1 and Supplementary
Figs. S2 and S3) as shown for other β-barrelled scaffold pro-
teins (Le Brun et al. 2011a, b; Shah et al. 2007; Terrettaz et al.
2002). Specific deuteration of just GGZctOmpA allowed for
this array protein to be distinguished from the hydrogenous
thioPEG and IgG and clearly highlights the 18 Å layer be-
tween the thioPEG / array protein layer and the IgG layer
(Fig. 3c). Although similar layers have been observed previ-
ously (Le Brun et al. 2008, 2011a), all components were hy-
drogenous so that the gap between the IgG and the protein
resistant thioPEG layer was previously unseen.
Protein G has previously been bound to surfaces and the
linkers used can be split into two categories resulting in either
oriented immobilisation or random immobilisation (Trilling
et al. 2013). This GGZctOmpA array clearly binds IgG in an
oriented manner with the neutron reflectivity data showing
that the IgG layer is 135 Å thick. Considering the dimensions
of IgG (143×77×40 Å3 (Silverton et al. 1977)), this would
indicate an orientation which is optimal for antigen binding
where the variable, antigen-binding domains are facing away
from the surface (Figs. 3c and 4). Although protein G can also
bind the antigen-binding Fab fragments of IgG (Tashiro and
Montelione 1995), isothermal titration calorimetry has shown
that the Ka of protein G binding to Fab fragments was two
Fig. 5 a Cross-linking IgG to an array of GGZctOmpA with BSSS.
30 μg mL−1 of mAb245 was incubated on the surface for 300 s at a
flow rate of 5 μL min−1 this was followed by wash with PBS buffer.
An incubation of 0.5 mM BSSS for 900 s was carried out to initialise
cross-linking with the reaction terminated with 1 M Tris–HCl pH 6.8
followed by a double wash of 100 mM HCl. The before and after
response to the crosslinking was assessed in the areas marked ‘A’ b
Binding of rNP (over a concentration range of 0.1 to 10 000 ng mL−1)
to mAb245 that has been cross-linked to an array of mAb245 with BSSS
cross-linker followed by binding of mAb108 (30 μg mL−1) at a flow rate
of 5 μL min−1. Between each concentration the array was regenerated
with a wash of 100 mM HCl. Data was subtracted from a data set of
0 ng mL−1 antigen
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orders of magnitude lower than binding to Fc fragments or
whole IgG, and that binding to the Fc domain dominated
(Lund et al. 2011).
Strong binding with little dissociation between the
GGZctOmpA array and mouse monoclonal IgG2b was dem-
onstrated (Fig. 2). Arrays of ZZctOmpA, which capture IgG
using the Z domain of Staphylococcal aureus protein A,
bound mouse monoclonal IgG2a with a Kd of 0.778 nM (Le
Brun et al. 2011a), which also indicates strong binding.
However, the subclass and species of origin of the IgG has
to be taken into account. Unlike mouse monoclonal IgG2a,
mouse monoclonal IgG2b and IgG1 bind to protein A poorly
(Björck and Kronvall 1984), whereas protein G binds all
mouse monoclonal IgG subclasses (Björck and Kronvall
1984; Eliasson et al. 1988). Therefore the advantage of using
protein G over protein Z as the IgG binding domain is the
ability of protein G to bind a much wider range of IgG classes
than protein A (Björck and Kronvall 1984). Eliasson et al.
(1988) showed that creating genetic fusions of the IgG-
binding domains of protein A and protein G can have additive
effects. In this work a Z domain from protein Awas used as a
linker between ctOmpA and protein G so the possibility of
some additive effect in this array exists.
Previous work has shown that a greater antigen binding can
be achieved through oriented immobilisation of IgG to sur-
faces (Bergström and Mandenius 2011; Kausaite-
Minkstimiene et al. 2010; Song et al. 2011) and this work
demonstrated complete saturation of the antigen binding sites
on the IgG (Fig. 2). Although complete saturation was
achieved, a discrete antigen layer could not be resolved in
the NR data; rather an overall increase in the nSLD and thick-
ness of the antibody layer was observed (Fig. 3d and
Supplementary Fig. S6). This indicates that the rNP, can adopt
multiple IgG-bound orientations allowed by the flexible hinge
region between Fc and Fab domains which orientates Fab in
different arrangements relative to the position of Fc without
affecting the overall shape of the IgG (Abe et al. 2010; Harris
et al. 1997; Saphire et al. 2002). This is reinforced by the
increased dissipation in the QCM-D traces suggesting flexi-
bility in the bound IgG structure (Supplementary Fig. S5). In
Fig. 4 we only show one IgG arrangement for clarity; however
the Figure does indicate that IgG fully occupied with rNP
would occupy a large molecular area and this could account
for the low volume fractions observed. SPR and QCM-D data
shows that the IgG to antigen ratio of mAb245 to rNP binding
is higher than that observed previously with an array of
ZZctOmpA using rabbit polyclonal anti-HSA IgG and human
serum albumin as antigen where a 25 % occupancy of the
antigen binding sites was achieved (Le Brun et al. 2011a).
The engineering of the array via the chemical cross-linking
of IgG to the protein G moieties prevents IgG dissociation
while retaining the detection capabilities of the original array
(Fig. 5). In addition crosslinking the IgG to protein G
stabilises the array enabling regeneration without having to
replenish primary antibody via a simple low pH solution
wash. A number of approaches have been used to cross-link
protein G or protein A to IgG for enhanced stability which
include using cyanamide (Bereli et al. 2011), dimethyl
pimelimidate (Bergström and Mandenius 2011), and
bis(sulfosuccinimidyl) linkers(Song et al. 2011). In this work
bis(sulfosuccinimdyl) linkers were used due to their mild con-
ditions for cross-linking and ease of use. The functional ends
of the cross-linkers were separated by different spaced cross-
linkers with each successfully cross-linking the IgG and pro-
tein G. Previous cross-linking studies, have found that the
orientation of the IgG is more important than the cross-
linking reagent (Kausaite-Minkstimiene et al. 2010) and this
work supports this.
P rev ious work c rea t ing membrane pro te in –
immunoglobulin-binding domain chimeras have only been
tested against IgG that have been raised against model pro-
teins such as albumin (Le Brun et al. 2011a, b). By creating the
GGZctOmpA molecule a wider range of monoclonal IgG
subtypes can be bound which increases the prospect for a
larger range of epitopes from ‘real world’ analytes to be de-
tected. In this work the molecule that was chosen for proof-of-
concept was recombinant influenza A nucleoprotein which is
currently the basis of a number of point-of-use diagnostic tests
for influenza (Hatchette 2009; Peters et al. 2013).
5 Conclusions
This work has revealed how nanoscale components
(engineered protein, alkane thiol and IgG) can self-assemble
into an array onto surfaces for potential microscale devices.
The antigen used for the proof of concept was nucleoprotein
from influenza, creating a label-free platform that is amenable
to both SPR and QCM-D techniques and sensitive to the pres-
ence of flu antigens. Crosslinking the IgG to the array enables
the benefits of non-covalent self-assembly to be used in a
stable covalent structure. Probing the interfacial structure of
the array by neutron reflectometry using both conventional
isotope contrasts and magnetic contrasts showed a structured
array with optimal IgG orientation for antigen capture.
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